Cover Image
Market Research Report

Use of Telemedicine in the United States (US) during the COVID-19 Pandemic - Coronavirus Disease 2019 (COVID-19) Sector Impact

Published by GlobalData Product code 955241
Published Content info
Delivery time: 1-2 business days
Price
Back to Top
Use of Telemedicine in the United States (US) during the COVID-19 Pandemic - Coronavirus Disease 2019 (COVID-19) Sector Impact
Published: August 1, 2020 Content info:
Description

Prior to the COVID-19 pandemic, telemedicine had not reached its full potential in the US, with several barriers preventing its widespread uptake, including reimbursement and access issues, lack of awareness, resistance to change, preference for in-person care, and technical and connectivity issues.

It is widely anticipated that COVID-19 may be the tipping point for telemedicine as the full potential of the technology is increasingly realized by patients, healthcare systems, and payers. As a result of the pandemic, regulations and policies governing reimbursement and use of telemedicine have changed significantly, leading to expanded access and an unprecedented demand for these services. The report assesses the use of live videoconferencing technologies, which allow the provision of on-demand, virtual, outpatient care during the COVID-19 pandemic as a result of social distancing and lockdown measures.

Scope

  • The main scope of this report is the use of live videoconferencing technologies, which allow the provision of on-demand, virtual, outpatient care during the COVID-19 pandemic as a result of social distancing and lockdown measures.
  • It assesses the use of telemedicine in the US prior to the COVID-19 pandemic, including the reimbursement environment.
  • It also provides an overview of the current landscape, including changes to different regulatory and reimbursement policies that have facilitated widespread expansion of the technology.
  • It includes primary research from physician surveys and interviews, and healthcare industry polls.
  • The report also provides an evaluation of the main opportunities and challenges currently facing the telemedicine sector in the US.
  • It includes a breakdown of the US telemedicine market with a focus on companies that provide standalone patient and physician on-demand telemedicine platforms. This includes analyses of third-party mobile app downloads and website traffic data to demonstrate the surge in demand witnessed during the pandemic.
  • Deals in the telemedicine sector since 2019 are also analyzed, including funding, strategic partnerships, and mergers and acquisitions (M&As).
  • There are also a number of case studies looking at different competitors and therapy areas such as mental health and inflammatory bowel disease (IBD).

Reasons to Buy

  • Develop business strategies by understanding how telemedicine is being used today and how the technology is expected to affect the healthcare sector in the future.
  • Stay up to date on the key players in the telemedicine space and where they sit in the value chain.
  • See what activities telemedicine players, healthtech companies, payers, and biopharmaceutical companies are undertaking in the space.
  • Identify emerging industry trends to gain a competitive advantage.
  • Identify opportunities for partnerships with telemedicine companies.
Table of Contents
Product Code: GDHCHT169

Table of Contents

1. Table Of Contents

  • 1.1. List Of Figures
  • 1.2. List Of Tables

2. Introduction

  • 2.1. What Is Telemedicine?
  • 2.2. Types Of Telemedicine
  • 2.3. Benefits Of Telemedicine
  • 2.4. Barriers To Telemedicine

3. Telemedicine Sector Before COVID-19

  • 3.1. Use Of Telemedicine Had Been Increasing But Was Still Low
  • 3.2. Telemedicine Regulation In The Us Before COVID-19

4. Telemedicine Sector During COVID-19

  • 4.1. Changes To Telemedicine Policies During The COVID-19 Pandemic
    • 4.1.1. Expansion Of Medicare Coverage
    • 4.1.2. Changes To State Legislation
    • 4.1.2.1. Medicaid
    • 4.1.2.2. Commercial Health Plans
    • 4.1.3. Relaxation Of Hipaa Rules
    • 4.1.4. Funding For Healthcare Providers To Improve Telehealth Capabilities
  • 4.2. Increased Demand For Telemedicine During The Pandemic
    • 4.2.1. Hospitals And Healthcare Providers
    • 4.2.2. Payers
    • 4.2.3. Telemedicine Companies
  • 4.3. Access To Telemedicine In The Us After COVID-19

5. What Do Physicians And The Healthcare Industry Think?

  • 5.1. Specialist Primary Research
  • 5.2. Healthcare Industry Polls

6. Opportunities And Challenges For Telemedicine In The Us

  • 6.1. Opportunities
    • 6.1.1. Changes To Certain Telemedicine Regulations Likely To Be Made Permanent
    • 6.1.2. Continued Acceptance Of Digital Health Technologies
    • 6.1.3. Advances In Remote Patient Monitoring And Mhealth
    • 6.1.4. The Growing Aging Population And Chronic Disease Management
    • 6.1.5. Increased Demand For Telemedicine In Mental Health
    • 6.1.6. Addressing Physician Shortages In Primary Care
    • 6.1.7. Supporting Young Adults Without Primary Care Physicians
    • 6.1.8. Reaching Underserved And Uninsured Populations
    • 6.1.9. Increased Funding And Strategic Partnerships In Telemedicine
  • 6.2. Challenges
    • 6.2.1. Raising Patient And Provider Awareness
    • 6.2.2. Loss Of Employer Health Insurance During The COVID-19 Pandemic
    • 6.2.3. Overcoming Privacy And Security Concerns
    • 6.2.4. Technology And Connectivity Requirements
    • 6.2.5. Integration Of Telemedicine Into Existing Healthcare It Systems

7. Market Analysis

8. Appendix

List of Tables

  • Table 1: Common Types of Services Provided by Telemedicine Companies
  • Table 2: Medicaid Telemedicine Coverage in Response to COVID-19
  • Table 3: Breakdown of State Actions on Telemedicine Coverage by Commercial Payers During the Pandemic
  • Tab

List of Figures

  • Figure 1: Telemedicine Is a Subset of Telehealth
  • Figure 2: Benefits of Telemedicine
  • Figure 3: Patient and Physician Barriers to Telemedicine Use
  • Figure 4: Use of Telehealth is Increasing and is Driven by Non-Hospital-Based Provider-to-Patient Interactions
  • Figure 5: Percentage of Large Employer Plans Covering Telemedicine, 2015-2019
  • Figure 6: Timeline of Key Regulatory and Policy Changes Related to Telemedicine in the US
  • Figure 7: State Mandated Expansion of Telehealth Services by Commercial Payers During the COVID-19 Pandemic
  • Figure 8: US Physicians' Use of Telemedicine Before the COVID-19 Pandemic
  • Figure 9: Change in the Proportion of US Physicians Using Telemedicine During the COVID-19 Pandemic
  • Figure 10: US Physicians' Expected Use of Telemedicine After the COVID-19 Pandemic
  • Figure 11: Industry Perspective on the Impact of Telemedicine During the COVID-19 Pandemic
  • Figure 12: Industry Perspective on the Main Benefits of Telemedicine
  • Figure 13: Industry Perspective on Challenges to the Adoption of Telemedicine During the COVID-19 Pandemic
  • Figure 14: Industry Perspective on Areas Most Suitable for Continued Telemedicine Adoption
  • Figure 15: Ways to Address Clinical Trial Disruptions Related to the COVID-19 Pandemic
  • Figure 16: Types of On-Demand Urgent Care Telemedicine Providers
  • Figure 17: Leaders and Challengers in the On-Demand Urgent Care Telemedicine Space
  • Figure 18: Global Mobile App Downloads Across Key Telemedicine Players, July 2019-June 2020
  • Figure 19: Website Traffic for Leading Telemedicine Platforms for Patients, July 2019-June 2020
  • Figure 20: Website Traffic for Challenger Companies with Telemedicine Platforms for Patients, July 2019-June 2020
  • Figure 21: Website Traffic for Leading Telemedicine Software/Platforms for Providers, July 2019-June 2020
  • Figure 22: Website Traffic for Challenger Telemedicine Software/Platforms for Providers, July 2019-June 2020
  • Figure 23: Telemedicine Funding by Quarter, Q1 2019-Q2 2020
  • Figure 24: Established Telemedicine Partnerships, Q1 2019-Q2 2020
  • Figure 25: Telemedicine Provider Partnerships by Type
  • Figure 26: The Teladoc Mobile Application for Patients
  • Figure 27: Amwell: Doctor Visits 24/7 Mobile Application for Consumers
  • Figure 28: The HeyDoctor by GoodRx Mobile Application for Patients
  • Figure 29: The Doxy.me Platform for Physicians
  • Figure 30: Thera-LINK Appointment Scheduler on the Physician Platform
  • Figure 31: US Telemedicine Usage in IBD
  • Figure 32: Trending Keywords from Digital Pharma Influencers in March 2020
  • Figure 33: Tweets Related to Telemedicine from Top Digital Pharma Influencers in March 2020
Back to Top